Relative Strength Chart Summit Therapeutics Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 17:32:37 10/02/2026 GMT			5-day change	1st Jan Change
15.46 ^USD	+3.31%		+5.76%	-11.78%

01-29	Sector Update: Health Care Stocks Edge Higher Premarket Thursday	MT
01-29	Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy	CI

End-of-day quotes

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	SUMMIT THERAPEUTICS INC.	Bio Therapeutic Drugs	+3.21%	+5.76%	-11.78%	-24.73%	+92.88%	11.54B